Literature DB >> 9373628

Prevalence of cysticercosis in epileptics and members of their families in Burundi.

E Newell1, F Vyungimana, S Geerts, I Van Kerckhoven, V C Tsang, D Engels.   

Abstract

In the province of Bururi in Burundi, 103 epileptics and 72 control subjects from the same households were examined for cysticercosis. Antigen was detected by enzyme-linked immunosorbent assay in 4.9% of epileptic persons and in 4.2% of controls. Antibody was detected by enzyme-linked electroimmunotransfer blot assay (EITB) in 11.7% of epileptics and in 2.8% of controls. Neither difference was statistically significant, nor was a history of taeniasis significantly more frequent in epileptics than in controls. However, cysticercosis was significantly more frequently diagnosed by EITB in people with a history of taeniasis than in those without such a history. The prevalence of taeniasis in schoolchildren ranged between 0 and 1.0%. Meat inspection detected cysticercosis in 2% and 39% of pigs in 2 localities, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373628     DOI: 10.1016/s0035-9203(97)90251-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Cysticercosis and epilepsy in rural Tanzania: a community-based case-control and imaging study.

Authors:  Ewan Hunter; Kathryn Burton; Ahmed Iqbal; Daniel Birchall; Margaret Jackson; Jane Rogathe; Ahmed Jusabani; William Gray; Eric Aris; Gathoni Kamuyu; Patricia P Wilkins; Charles R Newton; Richard Walker
Journal:  Trop Med Int Health       Date:  2015-05-26       Impact factor: 2.622

2.  Magnitude of the disease burden from neurocysticercosis in a developing country.

Authors:  C Bern; H H Garcia; C Evans; A E Gonzalez; M Verastegui; V C Tsang; R H Gilman
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 3.  Incidence of epilepsy: a systematic review and meta-analysis.

Authors:  Anthony K Ngugi; S M Kariuki; C Bottomley; I Kleinschmidt; J W Sander; C R Newton
Journal:  Neurology       Date:  2011-09-06       Impact factor: 9.910

Review 4.  A review and meta-analysis of the impact of intestinal worms on child growth and nutrition.

Authors:  Andrew Hall; Gillian Hewitt; Veronica Tuffrey; Nilanthi de Silva
Journal:  Matern Child Nutr       Date:  2008-04       Impact factor: 3.092

5.  Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.

Authors:  Jin-Mei Xu; Luz P Acosta; Min Hou; Daria L Manalo; Mario Jiz; Blanca Jarilla; Archie O Pablo; Remigio M Ovleda; Gretchen Langdon; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman; Hai-Wei Wu
Journal:  J Trop Med       Date:  2010-03-29

Review 6.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 7.  Epilepsy and neurocysticercosis in sub-Saharan Africa.

Authors:  Andrea Sylvia Winkler; Arve Lee Willingham; Chummy Sikalizyo Sikasunge; Erich Schmutzhard
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

8.  Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

9.  Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa.

Authors:  Uffe Christian Braae; Christopher F L Saarnak; Samson Mukaratirwa; Brecht Devleesschauwer; Pascal Magnussen; Maria Vang Johansen
Journal:  Parasit Vectors       Date:  2015-06-12       Impact factor: 3.876

10.  Prevalence and risk factors associated with human Taenia solium infections in Mbozi District, Mbeya Region, Tanzania.

Authors:  Gloria Mwanjali; Charles Kihamia; Deodatus Vitalis Conatus Kakoko; Faustin Lekule; Helena Ngowi; Maria Vang Johansen; Stig Milan Thamsborg; Arve Lee Willingham
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.